版本:
中国

BRIEF-Nanoviricides, says company has sufficient cash to advance into clinical trials

Oct 11 Nanoviricides Inc :

* Nanoviricides has filed annual report, says company has sufficient cash to advance into clinical trials Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐